Newest Businesses in Maryland

Browse newly-funded private companies headquartered in Maryland. Sorted by filing date, with the most recent on top.

About Maryland

Maryland's Form D filings concentrate in Bethesda, Silver Spring, Rockville, and the broader I-270 corridor (biotech and healthtech), Baltimore (healthcare via Johns Hopkins, education via JHU and UMB), and Annapolis-adjacent defense-tech. Maryland's I-270 biotech corridor — known as 'DNA Alley' — hosts one of the densest biotech clusters in the US outside Boston and San Diego. Round sizes for biotech filings are large ($30M–$200M+). Defense-tech filings from NSA- and DoD-adjacent areas add distinctive structure. Delaware incorporation dominates; Maryland LLCs appear for real-estate vehicles.

In 2026, Maryland accounts for 50 catalogued filings totaling $301.7M, running at roughly 10.5 filings per week over the last 30 days.

Total raised
$301.7M
Median offering
$4M
Active cities
10
Last 30 days
45

Top cities

Featured Maryland companies in 2026

About private capital in Maryland

Maryland has moderate-to-high state taxes and a regulatory environment shaped by federal-sector proximity, distinctive life-sciences infrastructure, and strong research universities. The I-270 biotech corridor benefits from NIH/FDA proximity (both headquartered in the Bethesda/Rockville area) — many Maryland biotech filings involve former NIH or FDA staff. Johns Hopkins' research output produces steady spinout filings. NSA-adjacent cyber and defense-tech companies file from Columbia, Fort Meade, and Annapolis Junction areas. Real-estate vehicles target Maryland multifamily and the Baltimore industrial market. Operating companies incorporate in Delaware.

RLL, LLC

Biotech MD
Amount undisclosed

Maryland funding trends

Recent Maryland Form D filings show several patterns. First, I-270 biotech companies file constantly at mid-to-large stages, reflecting DNA Alley's density. Second, cybersecurity and defense-tech companies from the Fort Meade/NSA ecosystem file regularly with strategic investor participation. Third, Johns Hopkins spinouts in medical devices, diagnostics, and therapeutics file at steady rates. Fourth, Baltimore-metro real-estate vehicles appear. Fifth, federal-contractor-adjacent SaaS filings reflect DMV-metro dynamics. Maryland punches above its population weight in biotech and cyber filings.